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Background: There has been considerable interest in discovery of the genetic architecture of complex traits,
particularly age-related neurodegenerative disorders. To predict disease risk and to understand its genetic basis in
humans, it is necessary to study animal models. Our previous research on the accelerated-senescence OXYS strain has
revealed two quantitative trait loci (QTLs) on rat chromosome 1 that are associated with early cataract and/or
retinopathy as well as with behavioral abnormalities. Each locus was partially mapped within the introgressed
segments in a certain congenic strain: WAG/OXYS-1.1 or WAG/OXYS-1.2. Retinal transcriptome profiling of 20-day-old
congenic and OXYS rats by high-throughput RNA sequencing uncovered relevant candidate genes and pathways.
Nonetheless, the question remained open whether the same genetic components simultaneously have effects on
various manifestations of the accelerated-senescence phenotype in OXYS rats. The present study was designed to
analyze the genes of susceptibility to early neurodegenerative processes taking place in the OXYS rat retina and brain
and to assess their potential functional clustering. The study was based on the findings from recent publications
(including mapping of quantitative trait loci) and on comparative phenotyping of congenic rat strains.
Results: The backcrossing of Wistar Albino Glaxo (WAG) and OXYS strains to generate the congenics resulted in two
congenic strains with high susceptibility to cataract and retinopathy but with no obvious signs of Alzheimer’s disease-
like brain pathology that are specific for OXYS rats. Thus, the genes of susceptibility to brain neurodegeneration were
not introgressed into the congenic strains or there is a strong effect of the genetic background on the disease
phenotype. Moreover, the progression of retinopathy with age was relatively less severe in the WAG background
compared to the OXYS background. A comparative analysis of previously defined QTLs and congenic segments led to
identification of candidate genes with a suspected effect on brain neurodegeneration including the genes showing
differential expression in the congenic strains.
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Conclusion: Overall, our findings suggest that the cause of the cataract and the cause of retinopathy phenotypes in
OXYS rats may be genetically linked to each other within the introgressed segments in the WAG/OXYS-1.1 and/or
WAG/OXYS-1.2 congenic strains.
Keywords: Genetic architecture of complex trait, OXYS rats, Quantitative trait locus, Congenic strain, Alzheimer’s
disease, Age-related macular degenerationBackground
The lifespan and health-span are intricately entwined
complex traits influenced by many genes that can either
predispose to age-related diseases and accelerate aging
or slow the aging process [1, 2]. In recent years, large-
scale genetic studies advanced our understanding of the
genetic architecture of many complex heritable traits.
The term “genetic architecture” can be directly described
for any trait based on information regarding gene and al-
lele number, the distribution of allelic effects, and pat-
terns of their relations. The most common age-related
disorders in humans are heritable, meaning that a part
of the phenotypic variation is defined by the variation in
genetic components. Numerous findings reveal that the
molecular genetic mechanisms may have much in com-
mon, particularly for age-related neurodegenerative dis-
orders, including the most common senile dementia,
Alzheimer’s disease (AD), and age-related macular de-
generation (AMD), which is the leading cause of visual
impairment and blindness in the developed countries
[3–7]. Nevertheless, the complex underlying heredity in
most cases of AMD and AD remains elusive primarily
due to the lack of reliable samples at different stages of
the disease. Postmortem samples of brain or eye tissues
can be used only to observe the end results of neurode-
generative processes, which do not necessarily reflect
the mechanisms responsible for disease development.
Thus, much of research has been traditionally based on
the use of animal models, to both improve our under-
standing of the pathophysiological mechanisms of the
disease and to test novel therapeutic approaches [8–12].
We believe that the use of accelerated-senescence OXYS
rats, which spontaneously develop both AMD-like retin-
opathy and the key signs of Alzheimer’s disease, repre-
sent unique opportunities for research in this field.
The OXYS strain was derived from outbred Wistar
stock at the Institute of Cytology and Genetics by selec-
tion and inbreeding of Wistar rats that were sensitive to
the cataractogenic effects of galactose-enriched diet, as
described earlier [13, 14]. The development of cataracts
was induced in Wistar rats by galactose overconsump-
tion in the first five generations of inbreeding. Subse-
quently, only the rats with early spontaneous cataract
were selected and bred using brother-sister inbreeding
to generate the accelerated-senescence OXYS strain inthe 1970s. We have demonstrated that OXYS rats in-
herit the characteristic accelerated-senescence pheno-
type in a linked manner, including sarcopenia [15],
osteoporosis [16], AMD-like retinopathy [17, 18], and
AD-like pathology [13, 19]. These findings led to the use
of OXYS strain in the relevant basic research and in the
studies on therapeutic effectiveness of various drugs
[20–22]. We assumed that mutations affecting the devel-
opment of early cataract in senescence-accelerated
OXYS rats also have effects on early manifestation of
other age-related disorders. Using this strategy, we iden-
tified two quantitative trait loci (QTLs) on rat chromo-
some 1 that are associated with early cataract and/or
AMD-like retinopathy and with certain behavioral signs
of brain neurodegeneration in OXYS rats. The candidate
QTLs named QTL1 and QTL2 are located in the regions
of the microsatellite markers D1Rat30-D1Rat219 and
D1Rat219-D1Rat81, respectively [23]. To confirm the
findings, the segments of chromosome 1 of OXYS rats
within QTL1 and QTL2 were introgressed in interval-
specific congenic strains. The parental strains were
accelerated-senescence strain OXYS (the donor of seg-
ments of chromosome 1) and the inbred Wistar Albino
Glaxo (WAG) rat strain (as a recipient with a normal
phenotype). The rats selected from the 8th generation of
backcrossing to the WAG strain (Additional file 1: Fig-
ure S1) were mated to obtain the introgressed segments
in the homozygous state. The result was WAG.OXYS-
(D1Rat30-D1Rat219) and WAG.OXYS-(D1Rat219-
D1Rat81) rat congenic strains hereafter referred to as
WAG/OXYS-1.1 and WAG/OXYS-1.2, respectively.
Examination of the retinal transcriptome at 20 days of
age identified a number of candidate genes and function-
ally enriched pathways of differentially expressed genes
in WAG/OXYS-1.1 and WAG/OXYS-1.2 congenic
strains when compared with the OXYS parental strain.
Nevertheless, mapping by means of RNA-seq data
showed that the QTL-derived segments of OXYS
chromosome 1 were only partially introgressed in the
resulting WAG/OXYS-1.1 and WAG/OXYS-1.2 con-
genic strains [24]. The ultimate aim of the present study
was to gain a better understanding of the genes of sus-
ceptibility to neurodegenerative changes in the OXYS
retina and brain. To test our previous QTL-derived
hypothesis further, we carried out comprehensive
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congenic rat strains in comparison with the parental
strains. The advantages of the two congenic rat strains
allowed us to analyze the RNO1 candidate genes with a
specific emphasis on phenotypic variation.
Results
Analysis of phenotypic traits in WAG/OXYS-1.1 and WAG/
OXYS-1.2 congenic strains
Cataract and retinopathy progression with age
OXYS rats develop an early-onset ocular pathology
characterized by cataract and retinopathy, and the
cataract severity considerably progresses with age
against the background of neurodegenerative alter-
ations in the OXYS retina. To test whether the con-
genic WAG/OXYS strains develop a similar pathology,
we analyzed the progression of cataract and retinop-
athy in the experimental groups (n = 14 to 15) of the
parental (OXYS and WAG) and congenic (WAG/
OXYS-1.1 and WAG/OXYS-1.2) rat strains between
the ages of 2 and 12 months.
At 3 months of age, the clinical signs of cataract and
retinopathy were observed in 89% of lenses and in 100%
of retinas in OXYS rats (n = 30, Fig. 1); 9% of eyes in the
3-month-old OXYS group matched the 2nd stage of cata-
ract and 25% of eyes corresponded to the 2nd stage of
retinopathy according to the AREDS protocol [25]. The
severity of both cataracts and retinopathy progressed
dramatically with age in OXYS rats in agreement with
our prior data [17, 26, 27]. By 12 months of age, 27% of
OXYS lenses (n = 30) corresponded to the 1st stage, 53%
of lenses to the 2nd stage, and 20% of lenses to the 3rd
stage of cataract; the last did not allow us to evaluate the
state of ocular fundus. In 58% of 12-month-old OXYS
rat’s eyes, for which the evaluation was still possible, theFig. 1 The incidence of cataract and retinopathy in congenic (WAG/OXYS-
age of 2, 3, and 12 months. We did not observe any cases of retinopathy in
with the stages of cataract and retinopathy (n = 30 eyes). Colors are labeled
retinopathy, scoring 0–3, as explained in Methodspathological changes of the retina corresponded to the
2nd stage of disease. For comparison, only a single case
of the 1st stage cataract and no cases of retinopathy were
registered within the WAG experimental group [23].
The progression of cataract and retinopathy in WAG/
OXYS-1.1 and WAG/OXYS-1.2 rat strains differs clinic-
ally from both parental strains (Fig. 1). In 3-month-old
WAG/OXYS-1.2 rats, the signs of the 1st stage of cata-
ract and 1st stage of retinopathy were observed in 71%
of eyes (n = 30) with no signs of progression to the 2nd
stage for both diseases. At the age of 12 months, 100%
of WAG/OXYS-1.2 rats were characterized by lens alter-
ations, and 35% of WAG/OXYS-1.2 lenses corresponded
to the 2nd stage of cataract. We identified the signs cor-
responding to the 1st stage of retinopathy in 70% of the
eyes in 12-month-old WAG/OXYS-1.2 rats. We simi-
larly did not observe any signs of the 2nd stage of retin-
opathy even in 12-month-old animals.
In the group of 3-month-old WAG/OXYS-1.1 con-
genic rats, the signs of the 1st stage of cataract were ob-
served in 64% of lenses (n = 30), with no signs of
progression to the 2nd stage of cataract. By the age of
12 months, the incidence of cataracts had reached 100%
as in WAG/OXYS-1.2 rats. At 12 months of age, 50% of
WAG/OXYS-1.1 lenses showed the 1st stage of cataract,
and the other 50% of lenses the 2nd. At the age of
3 months, we observed the signs of the 1st stage of retin-
opathy in 53% of eyes of WAG/OXYS-1.1 rats, with no
cases of the 2nd stage. The number of affected animals
and eyes did not increase with age in WAG/OXYS-1.1
rats. Moreover, ophthalmoscopic examination of the
same animals at the age of 12 months revealed 100% re-
mission of retinopathy, just as in the results of periodic
ophthalmic examinations during the breeding WAG/
OXYS-1.2 rats. The remission has never been observed1.1 and WAG/OXYS-1.2) and parental (OXYS and WAG) rat strains at the
WAG rats at any age. Data are presented as a distribution of rat eyes
with 0 through 2 and correspond to a certain stage of cataract or
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therapeutic intervention.
In sum, our findings indicate that WAG/OXYS-1.1
and WAG/OXYS-1.2 rats develop cataracts and retinop-
athy, but the progression of both diseases was relatively
less severe in the WAG background compared to the
OXYS background even at 12 months of age.
Histological examination of rat retinas
At the next step, we compared the histological features
of the retina in the congenic (WAG/OXYS-1.1 and
WAG/OXYS-1.2) and parental (OXYS and WAG) rat
strains at the age of 3, 10, and 16 months. As we re-
ported earlier (data not shown), the development of ret-
inopathy in OXYS rats is accompanied by progressing
degenerative alterations that primary affect the RPE cells
and lead to choriocapillaris atrophy and a complete loss
of photoreceptor cells in the rats’ retina by the age of
24 months [17]. According the data of the present study,
at the age of 3 months, there were prominent abnormal-
ities of the choroidal vasculature, RPE cells, and neuro-
sensory cells in the retina of OXYS rats, while the retina
of WAG rats showed normal structure. Unlike the chor-
oid of WAG rats (Fig. 2a), the choroid of OXYS rats was
characterized by incident aggregation of blood cells, sta-
sis, and thrombosis of small vessels. The specific area of
vessels with signs of partial occlusion was significantly
greater in OXYS rats as well (Fig. 2b). In the photo-
receptor cells of OXYS rats, there were nuclear pyknosis
(the clumped chromatin) and disaggregation and dis-
orientation of membrane discs of outer segments
(Fig. 2c). In the inner retinal layers of OXYS rats, we ob-
served hyperchromatic pyknomorphic neurons and
swollen neurons in association with radial glial cells,a
Fig. 2 Retinas of 3-month-old WAG a and OXYS b c rats. a Open chorioret
the cellular prismatic pigment epithelium with prominent microvilli (white
hyperchromic oligodendrocyte with nuclear pyknosis in the layer of nerve
(white dashed arrow); hyperchromic pyknomorphic radial glial cells (white a
Stasis and sludge of the blood cells in the choroidal vessels (black dashed a
and disaggregation of the outer segments of photoreceptors (asterisk); the
arrows). Abbreviations: OPL, outer plexiform layer; INL, inner nuclear layer; I
layer, RPE, retinal pigment epithelium, Ch, choroid. The scale bar is 10 μmwhich were hyperchromic and pyknomorphic. In the
ganglionar layer of OXYS rats’ retina, some neurons
were pyknomorphic and chromolytic as well, indicative
of a decline in the reserve capacity of neurons and a
characteristic sign of hypoxia. The progression of these
abnormalities in OXYS rats to the age of 10 months was
accompanied by a significant reduction in thickness of
the photoreceptor cell layer and a reduction in the num-
ber of photoreceptor cell nuclei of the outer nuclear
layer, especially in the central part of the retina, while in
the WAG rats the retina remained normal.
Some degenerative changes were observed in the ret-
ina of 3-month-old WAG/OXYS-1.1 and WAG/OXYS-
1.2 congenic rats. In contrast to OXYS rats, these alter-
ations developed against the evident inflammatory back-
ground, including the mass migration of lymphocytes
and macrophages into the inner plexiform layer and
ganglion cell layer. Such a pattern is typical for AMD
patients, but not for the OXYS parental strain [28]. At
the same time, the predominantly damaged retinal layers
in congenic rats were the ganglion cell layer and the
inner nuclear layer. Disturbances of microcirculation
were identified such as the phenomena of blood cell sta-
sis and thrombosis of inner retinal vessels of the WAG/
OXYS-1.1 and WAG/OXYS-1.2 retinas (Fig. 3). Histo-
pathological features of retinal alterations in 10-month-
old congenic rats were generally similar to those ob-
served in age-matched OXYS rats. Furthermore, the
massive accumulation of lipofuscin granules was de-
tected in the RPE cells of OXYS rats, but not of con-
genic rats. The functionally active open choroid
capillaries with a few blood cells were observed in the
retina of WAG/OXYS-1.1 and in the retina of WAG/
OXYS-1.2 rats. Nevertheless, the specific area of choroidb c
inal vessels with a small amount of blood cells (white dotted arrows);
arrows). b The ganglion neuron nucleus with pyknosis (black arrow);
fibers (dashed black arrow); stasis of blood cells in the intraretinal vessel
rrows); hyperchromic pyknomorphic associative neurons (red arrows). c
rrows); a pyknotic nucleus of an RPE cell (black arrows); disorientation
photoreceptors containing a nucleus with pyknosis (white dotted
PL, the inner plexiform layer; ONL, outer nuclear layer; GL, ganglion cell
a b
Fig. 3 Retinas of 3-month-old WAG/OXYS-1.2 rats. a Migration of macrophages into the inner plexiform and ganglion layers (white arrows).
Migration of the perikaryon of the associative neuron into the inner plexiform layer (dashed black arrow). b Advanced intraretinal capillary with
phenomenon of the blood cells stasis (black arrows); lymphocytic infiltration (white arrows); NGC: the nucleus of the ganglion neuron.
Abbreviations: OPL: outer plexiform layer; INL: inner nuclear layer; IPL: the inner plexiform layer; ONL: outer nuclear layer; GL: ganglion cell layer.
The scale bar is 10 μm
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WAG/OXYS-1.1 rats when compared to age-matched
OXYS and WAG/OXYS-1.2 rats (p = 0.007 for pairwise
comparisons). At this age, a significantly increased area
of inner retinal vessels was observed in the retina of rats
of both congenic strains when compared to OXYS rats
(p < 0.05).
Photoreceptors with the signs of pyknosis as well as
the migration of some photoreceptor nuclei to the outer
plexiform and the inner nuclear layers were detected in
the retinas of both WAG/OXYS-1.1 and WAG/OXYS-
1.2 congenic rats. The qualitative evaluation revealed
that the number of rows of photoreceptor nuclei was
greater in the congenic rats than in age-matched OXYS
rats even at age 10 months. A comparative reduction in
the number of photoreceptor nuclei of the outer nuclear
layer in WAG/OXYS-1.1 and WAG/OXYS-1.2 rats with
respect to OXYS rats was observed by the age of
16 months during partial occlusion of choroidal vessels
and flattening of the RPE cells (Fig. 4).a
Fig. 4 Retinas of 10-month-old WAG/OXYS-1.2 a and WAG/OXYS-1.1 b rats
number of the photoreceptors in the retina of a 16-month-old WAG/OXYS
intraretinal capillaries (red arrows); the flattening of the RPE cells, RPE cells c
mononuclear phagocytes within the subretinal space with RPE detachmen
flattening of the RPE cells, RPE cells containing a nucleus with pyknosis (bla
neurons (black dashed arrows). Abbreviations: OPL: outer plexiform layer, IN
layer; GL: ganglion cell layer, RPE: retinal pigment epithelium, PhL: photorecIn sum, the histopathological assessment of rat retinas
confirmed the presence of pathological changes in
OXYS, WAG/OXYS-1.1, and WAG/OXYS-1.2 rats (but
not in WAG rats) as early as age 3 months. The retinop-
athy features including the predominantly damaged ret-
inal layers differ between the congenic strains and OXYS
strain but seem generally similar between WAG/OXYS-
1.1 and WAG/OXYS-1.2 strains. By the age of
16 months, we detected major differences between the
congenic and OXYS rats in the retinal blood supply
(Additional file 1: Figure S1).
Evaluation of neurodegenerative brain alterations
Behavioral testing
In the present study, 3-month-old OXYS rats demon-
strated considerably reduced locomotor activity in the
open field (OF) test as compared to age-matched WAG
controls: the number of crossed squares was significantly
lower in OXYS rats (p <0.05). According to pairwise
comparisons no significant differences were detected inb c
. The thinning of the outer nuclear layer with a reduction in the
-1.2 rat c. a The open intraretinal vessels (red arrows). b Open
ontaining a nucleus with pyknosis (white dashed arrows); migration of
t (black dashed arrow). c Open intraretinal capillaries (red arrows); the
ck arrows); the destructive changes in neurosensory and associative
L: inner nuclear layer; IPL: the inner plexiform layer; ONL: outer nuclear
eptor layer. The scale bar is 10 μm
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OXYS rats. Among WAG/OXYS-1.2 rats, the number of
crossed squares in the OF test varied considerably and
was significantly greater than that in OXYS rats (p =
0.0001), likely indicating a reduced level of anxiety (Add-
itional file 1: Figure S2). In the elevated plus-maze
(EPM) test, the rats of both congenic strains did not dif-
fer from either WAG or OXYS rats in the level of loco-
motor activity and anxiety (analyzed by means of the
number of entries into the open arms and the time spent
in the open arms).
In order to estimate the reference memory, the learn-
ing ability of 5-month-old OXYS, WAG, and congenic
rats (n = 7 to 8 per experimental group) was assessed in
the 8-arm radial maze. Performance of working and ref-
erence memory was combined for four training periods
according the standard test variation: the 1st training
period, day 1; the 2nd, days 2–4; the 3rd, days 5–7; and
the last training period, days 8–10 of training. The num-
ber of total arm entries (used to estimate a rat’s horizon-
tal locomotor activity) of OXYS rats in the 8-arm radial
maze was significantly lower, and the number of groom-
ing events (used to estimate animal’s anxiety) was higher
than in WAG and both congenic strains (p <0.05).
WAG/OXYS-1.1 rats also showed a tendency for an in-
crease in the number of grooming acts in the 2nd train-
ing period (p = 0.645). No significant differences in the
number of working memory errors (the number of re-
entries into already visited arms of the maze during test-
ing) and memory error rates (the ratio of the number of
entries into the arms nonreinforced with a food stimulus
to the total number of entries during test sessions,
expressed in percentage points) for all training periodsFig. 5 Results for the two-dimensional principal component analysis (PCA)
According to the results of PCA, the rats of two congenic strains, WAG/OXY
of WAG rats, than to those of OXYS rats. Legend: PC1 and PC2: principal cowere demonstrated for the congenic and parental WAG
experimental groups. Nonetheless, the Monte Carlo
sampling of the recorded parameters revealed significant
interstrain differences between all experimental groups:
OXYS, WAG, WAG/OXYS-1.1, and WAG/OXYS-1.2
rats (p <0.01 for each pairwise comparison). Fig. 5 de-
picts the results of principal component analysis (PCA)
of combined rat behavioral parameters in the 8-arm ra-
dial maze.
Morphometric analysis of the rat brain
According to the MRI analysis, the rats of both congenic
strains developed some signs of neurodegenerative alter-
ations by 12 months of age, but those were found to be
less pronounced than in 12-month-old parental OXYS
rats. Demyelination is the process where the myelin
sheath of neuronal cells is damaged. At the age of
12 months, the demyelination lesions were detected in
the brains of 100% of OXYS rats, 32% of WAG rats, 25%
of WAG/OXYS-1.1 rats, and 43% of WAG/OXYS-1.2
rats. At the same time, the foci of demyelination were
observed generally in the corpus callosum of WAG/
OXYS-1.1 rats and in the hippocampus of OXYS and
WAG/OXYS-1.2 rats (the total number of demyelination
lesions is given in Fig. 6a). The total number of demye-
lination lesions in T2-weighted images was orders of
magnitude greater in the corpus callosum of OXYS rats
than in either congenic strain (p <0.001) and twice larger
in the hippocampus of OXYS rats than in the hippocam-
pus of the WAG/OXYS-1.2 congenic strain (p <0.091, a
nonsignificant tendency). Enlargement of the lateral ven-
tricles, called ventriculomegaly, is associated with neuro-
degenerative diseases, such as Alzheimer’s disease, whileof rat behavioral parameters recorded in the 8-arm radial maze test.
S-1.1 and WAG/OXYS-1.2, proved to be much closer to the parameters































Fig. 6 An MRI morphometric study of the brain of 12-month-old OXYS, WAG/OXYS 1.1, and WAG/OXYS-1.2 rats. a The total number of
demyelinating foci is significantly greater in the OXYS brain than in the brain of the congenic and WAG rats. b The lateral ventricles in the
congenic and WAG rats are enlarged when compared with OXYS rats. c Axial slices of the brain of 12-month-old WAG/OXYS-1.2, WAG, and OXYS
rats. The foci of demyelination (white arrows) and the increase in the size of lateral ventricles in WAG and congenic rats (white dotted arrows) are
visible. Not all congenic and WAG rats have the demyelination lesions. The data are shown as mean ± SEM. Abbreviation: LV, lateral ventricles;
*P < 0.05 for differences between the strains
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an imbalance between production and resorption of
cerebrospinal fluid, typical for neurodegenerative dis-
eases [29, 30]. According to the data, the specific area of
the cerebral lateral ventricles was increased in WAG and
both congenic strains when compared with OXYS rats
(p <0.001) (Fig. 6b, c). Thus, the present study confirmed
the presence of previously described neurodegenerative
changes in the brain of OXYS rats, progressing dramat-
ically with age [13]. Nonetheless, there were no signifi-
cant differences between rats of congenic (WAG/OXYS-
1.1 and WAG/OXYS-1.2) and WAG strain in terms of
morphological and functional brain parameters.
Comparison of the results on candidate genetic loci
mapping on rat chromosome 1
Candidate QTL1 and QTL2 loci on rat chromosome 1
were associated with early cataract and retinopathy de-
velopment as well as with some characteristic behavioral
parameters of OXYS rats [23]. The effects on cataract
and retinopathy were confirmed in WAG/OXYS-1.1 and
WAG/OXYS-1.2 congenic strains. In the present study,
we showed convincingly that animals carrying OXYS al-
leles at each of congenic loci were not susceptible to de-
velopment of brain lesions when compared with the
WAG parental strain. Thus, we could reasonably assume
that in the congenic segments, there was likely no gene
or gene cluster whose structural and/or functional de-
fects led to cerebral pathophysiological processes.
Assuming that the point of largest linkage was esti-
mated in the 95% confidence interval, we produced acomplete list of genes within each of the two previously
determined QTLs (Additional file 2: Table S1). Accord-
ing to our previous RNA-seq-based analyses, the candi-
date QTL1 and QTL2 loci do not exactly match the
congenic segments: the regions of OXYS chromosome 1
that were introgressed into WAG/OXYS-1.1 or WAG/
OXYS-1.2 congenic strains. Therefore, we compared the
list of genes with a) the list of genes located within the
mapped congenic segments and b) with those genes that
were identified within rat QTL loci associated with be-
havioral abnormalities according to the Rat Genome
Database [31]. The Venn diagram in Fig. 7 shows the re-
lations among the three overlapping sets of genes (Add-
itional file 2: Tables S2–S5). In particular, we found that
genes involved in the synaptic transmission, in the endo-
plasmic reticulum membrane, cell adhesion, protein
complex biogenesis and, in particular, the ribonucleopro-
tein complex are represented in the intersection of 1498
genes, which fall into both of RGD QTL and QTL1/
QTL2 regions but do not fall into congenic segments
(Additional file 3). Table 1 shows the top enriched GO
categories in this set of 1498 genes. Some of the
identified genes were particularly relevant to the neuro-
logical phenotype, including 11 genes of Alzheimer’s
disease-presenilin pathway [Panther: P00004], and 8
genes of Alzheimer’s disease-amyloid secretase pathway
[Panther: P00003].
After that, we compared the same list of 1498 genes
with the list of genes for which the differential expres-
sion was reported previously [24] in WAG/OXYS-1.1 or
WAG/OXYS-1.2 retinas when compared with the OXYS
Fig. 7 The Venn diagram showing overlaps among the three analyzed sets of RNO1 genes. The genes located within the previously determined
QTL1 and QTL2 [23], the genes located within the mapped congenic segments in WAG/OXYS-1.1 and WAG/OXYS-1.2 rat congenic strains [24],
and the genes located within rat QTLs, presented in RGD were analyzed. The number of genes in each group as reported by RGD is shown in
the corresponding field
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uniquely mapped to the reference genome were analyzed
at the cutoff of |log2FC| ≥ 1.0; padj < 0.1 (where FC is fold
change) for the WAG/OXYS-1.1 versus OXYS and
WAG/OXYS-1.2 versus OXYS differentially expressed
(DE) genes. We found that the level mRNA of the Asrgl1
gene, also known as Gliap, was significantly higher in the
retina of both congenic rats, than in the retina of OXYS
rats (adjp-value 0.0342 and 0.0000013 for WAG/OXYS-
1.1 and WAG/OXYS-1.2 strains, respectively). The level
of mRNA for two genes among 1498, Dhdh, and Gpha2
(located within previously reported QTL1 and QTL2, re-
spectively) was significantly lower in the retina of WAG/
OXYS-1.2 rats than in the retina of OXYS rats (adjp-value
0.0863 and 0.0561, respectively). Thus, our data are sug-
gestive of a differential effect of the genetic background
on regulation of the Asrgl1, Dhdh, and Gpha2 genes.
In addition, the chromosomal regions delineated in
the intersection of the Arrd2 locus, QTL for age-related
retinal degeneration, and the congenic segment intro-
gressed into WAG/OXYS-1.2 strain contain the poten-
tial candidate gene Fxn, frataxin [RGD: 1565754], which
was shown to be associated with mitochondrial abnor-
malities, neurite degeneration, and apoptotic cell death.Discussion
Studying ageing is a challenging task because of the
complexity of the aging process and the asynchrony of
senescence that was documented in humans, laboratory
models, and wild animals [32–34] as well as among
phenotypic traits of a natural population [35]. The aging
population is diverse genetically and is heterogeneous in
terms of diseases and comorbidities. Because it is highly
likely that the same mechanisms that drive aging also
underlie multiple age-related chronic diseases, elucida-
tion of these mechanisms may shed light on the aging
process [36]. Model animals showing spontaneous onset
of a pathology similar to that of a human disease have
proven invaluable in this regard. Consequently, in the
context of comparative studies on aging, there is a need
for a greater number of diverse models of aging and age-
related disorders in relation to any species of laboratory
animals [37].
Such an approach to research can improve our under-
standing of the genes and their allelic variants that cause
a disease early in life or predispose an individual to in-
creased risk of a chronic disease. Thus, this approach
may help to develop strategies to prevent or delay
chronic medical conditions affecting the elderly. A
Table 1 A DAVID report on top representative enriched GO categories for the set of 1498 analyzed RNO1 genes. Some broad
categories associated with sensory perception and olfaction were excluded
Category Term Count P Value
GOTERM_BP_FAT GO:0050877, neurological system process 210 5.847029238110996E-27
GO:0050890, cognition 192 7.182253845261601E-27
GO:0007186, G-protein coupled receptor protein signaling pathway 202 4.097419923337612E-18
GO:0007166, cell surface receptor linked
signal transduction
222 6.215501968023257E-13
GO:0006414, translational elongation 15 7.078201738398857E-4
GO:0015671, oxygen transport 5 0.0032335241561143833
GO:0051259, protein oligomerization 22 0.00669002198721339
GO:0006836, neurotransmitter transport 13 0.009111208533119846
GO:0006974, response to DNA damage stimulus 24 0.01657678971411233
GO:0007268, synaptic transmission 21 0.019269327596189923
GO:0033554, cellular response to stress 34 0.04221800073686602
GO:0001505, regulation of neurotransmitter levels 10 0.042368672097131105
GO:0006261, DNA-dependent DNA replication 6 0.04679384686345697
GOTERM_CC_FAT GO:0031224, intrinsic to membrane 323 1.0902250124386092E-7
GO:0033279, ribosomal subunit 12 0.008194644308006482
GO:0045211, postsynaptic membrane 16 0.013015080960369218
GO:0045202, synapse 33 0.020591521818732007
GO:0022626, cytosolic ribosome 8 0.02681660832216637
GO:0030894, replisome;
GO:0043596, nuclear replication fork
4 0.03589946869050226
Count: the number of genes in a category; the P values were given by DAVID
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appropriate phenotype. Phenotypes of particular value
for genetic research are those with high heritability and
with close relations to gene products or pathways. A
study involving congenic rat strains corresponding to
disease states seems a sensible place to start.
As reported, two promising QTL locations on the 1st
chromosome of OXYS rats were potentially associated
with the accelerated-senescence OXYS phenotype, in-
cluding the effects on retinopathy, and at the same time,
on some behavioral parameters (QTL1 is bounded by
microsatellite markers D1Rat30 and D1Rat219) and on
cataract, retinopathy, and some behavioral parameters
together (QTL2 is in the vicinity of D1Rat219 and
D1Rat81) [23]. We derived two congenic strains to verify
the effects of each candidate locus: WAG/OXYS-1.1 and
WAG/OXYS-1.2, respectively. The candidate genes were
mapped within the certain congenic intervals on
chromosome 1 by means of RNA sequencing (RNA-Seq)
data [24]. We found that RNO1 segments that were
introgressed from the OXYS parental strain spanned
81.1 Mbp in total (from position 8900000 to position
105000000 bp and from 178 000 000 to 275 000 000 bp,
respectively) and identified clearly defined breaks in both
regions. These congenic loci had effects on thedevelopment and progression of both cataract and retin-
opathy in both WAG/OXYS-1.1 WAG/OXYS-1.2 con-
genic strains. Such significant experimental data led to
the assumption that the effects of the candidate genetic
component may be dual: affecting the development of
both ocular disorders. Thus, the present study was
aimed at a thorough comparative analysis of the pheno-
types of original congenic rat strains in order to compare
the phenotypic effects of the proposed QTL locations
and the actual congenic chromosome regions.
Phenotypic characterization of WAG/OXYS-1.1 and WAG/
OXYS-1.2 rat strains
In the present study, we assessed the progression of
cataract and retinopathy with age in WAG/OXYS-1.1
and WAG/OXYS-1.2 rats through a series of successive
ophthalmological examinations as compared to OXYS
and WAG parental rats. We showed that the number of
cataract-affected and retinopathy-affected congenic ani-
mals was markedly increasing with age, but the severity
of both diseases in congenic rats was lower than in
OXYS rats even by 12 months of age. Moreover, the
clinical signs of retinopathy differed in congenic and
parental rats, pointing to a strong effect of the genetic
background. The histological examination confirmed the
The Author(s) BMC Genetics 2016, 17(Suppl 3):153 Page 146 of 191conclusion and revealed the characteristic features of
retinopathy development in congenic and OXYS strains.
Both WAG/OXYS-1.1 and WAG/OXYS-1.2 strains dif-
fered from OXYS rats by the parameters of the inner
retinal blood supply and the inflammatory background
of retinopathy development as indicated by the migra-
tion of immunocompetent cells into the inner plexiform
and ganglion cell retinal layers. Accordingly, we con-
cluded that similar mechanisms may underlie disease de-
velopment and progression with age in both congenic
strains.
One possible cause of the observed differences (in the
retinopathy progression between OXYS and congenic
strains, including the observed remission of 1st-stage ret-
inopathy in WAG/OXYS-1.1 rats by age 12 months) is
the differences in the state of animal immune system.
Experimental and clinical lines of evidence strongly indi-
cate the pathogenic role of the immunological processes
in AMD, including the data on recruitment of macro-
phages, complement activation, microglial activation,
and accumulation within the macula area [28, 38]. Be-
cause AMD is not accompanied by an intense inflamma-
tory reaction, it is possible that age-related dysregulation
of reparative parainflammatory mechanisms in the eye
leads to a low-grade chronic inflammatory response in
the context of AMD pathology [39]. We have previously
found a lack of a T-cell component of the immune sys-
tem during rapid involution of the thymus in OXYS rats
[40]. In support of this notion, we observed selective
changes in the expression of genes related to the im-
mune system and inflammatory responses in the retina
of OXYS rats when compared with Wistar rats [18] and
when compared with congenic rats [24]. These specific
alterations at both the prodromal (20 days) and the ad-
vanced (18 months) stages of retinopathy may lead to a
specific metabolic basis for development and progression
of the disease, with some variation between the exam-
ined rat strains. Thus, the gene or genes within mapped
congenic segments do have an effect on the accelerated-
senescence phenotype in OXYS rats, revealing some
overlap because they cause early cataract and retinop-
athy in both WAG/OXYS-1.1 and WAG/OXYS-1.2 rat
strains.
The level of significance of statistical parameters used
for QTL mapping in the examined F2 population
allowed us to suggest that QTL1 and QTL2 could affect
some behavioral parameters, including the time to enter
the central area of the OF test and the number of
grooming acts (for QTL2 only) in the EPM test. Thus,
we conducted the behavioral testing, as well as MRI in
order to determine the presence of neurodegenerative
changes in the brain of congenic rats.
Age-related neurodegenerative disorders, including
AD, are characterized by a progressive cognitive declineand memory dysfunction. Our recent results offer prom-
ising evidence of the relevance of the OXYS rat model
to the neurodegenerative processes that are observed in
AD. The profile of AD-like pathology in OXYS rats is
characterized particularly by the manifestation of behav-
ioral alterations and learning and memory deficits as
early as by 3 months of age [41–43]. In contrast, the
present study showed no considerable differences in the
locomotor activity, levels of anxiety, and learning ability
between the parental WAG strain and congenic WAG/
OXYS-1.1 and WAG/OXYS-1.2 strains. The results of
PCA were as expected, given that a complex trait is ana-
lyzed and a large part of the congenic genome corre-
sponds to the WAG strain.
Emerging evidence reveals widespread demyelination
in aging and disease, but the nature of myelin pathology
in the specific cases has not been well studied. Several
studies have suggested, however, that certain structural
MRI biomarkers possess some degree of diagnostic
power in the differential diagnosis. Recent studies on
animal models of AD revealed focal demyelination
within amyloid-β plaques in the hippocampus [44]. MRI
showed that the signs of neurodegenerative changes
were present in OXYS rats at the age of 3 months and
were well pronounced at the age of 12 months [13].
Nevertheless, we did not detect significant signs of de-
myelination in the brain of congenic rats in the present
study. There was a substantially smaller number of de-
myelination lesions on T2 WI in the brain of congenic
rats than in the brain of OXYS rats. The enlargement of
the lateral ventricles, called ventriculomegaly, is associ-
ated with neurodegenerative diseases, such as AD,
whereas the initial cause is often unknown. This state of
affairs may be due to an imbalance between production
and resorption of cerebrospinal fluid, typical for neuro-
degenerative diseases [29, 30]. On the other hand, when
compared to OXYS rats, the specific area of the cerebral
lateral ventricles was significantly larger in all three
strains: WAG, WAG/OXYS-1.1, and WAG/OXYS-1.2.
Thus, we likely are witnessing a specific characteristic of
the WAG parental strain in congenic strains. According
to our data, we believe that the observed enlargement of
the lateral ventricles is not associated with behavioral
abnormalities or memory deficits in congenic rats.
We can reasonably assume that the gene/genes that
have structural and/or functional defects with an effect
on brain pathophysiological processes in OXYS rats, do
not likely fall into the congenic RNO1 segments in
WAG/OXYS-1.1 and WAG/OXYS-1.2 strains. Accord-
ing to our findings, the genetic factors affecting the de-
velopment of early cataract and retinopathy do not have
effects on the accelerated-senescence brain phenotype in
OXYS rats, at least independently of the genetic
background.
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segments in WAG/OXYS-1.1 and WAG/OXYS-1.2 strains
Key unaddressed questions in biology are whether genes
are physically clustered with respect to their known
functions or phenotypic effects; these questions lead to
the special interest in analysis of QTL regions. In the
present study, we compared the list of genes located
within the putative QTL1 and QTL2 loci [23], in the ini-
tially mapped congenic segments [24], and within known
rat QTL loci strongly associated with retinopathy or be-
havioral abnormalities according to RGD. The enrich-
ment analysis was used to extract candidate pathways or
individual candidate genes that could correlate with the
phenotypic outcome in at least two rat strains.
We found that the genes associated with the AD-
presenilin pathway [Panther: P00004] and the AD-
amyloid secretase pathway [Panther: P00003] did not fall
into the RNO1 regions, which were introgressed into the
congenic rat strains from the parental OXYS strain.
Therefore, these genes may have effects on the signs of
accelerated brain aging in OXYS rats, which are not
manifested in congenic rats. The genes of the AD-
presenilin pathway and AD-amyloid secretase pathway
are known to be particularly relevant to the neurological
phenotype and may contribute to the progression of
most common age-associated neurodegenerative dis-
eases such as Alzheimer’s and Parkinson’s diseases [45–
47]. We have recently demonstrated that the pathogenic
pathways enriched with DE genes in the retina of OXYS
rats when compared to congenic rats may also affect
AD-related pathways. Thus, existing data indicate that
the development of the accelerated-senescence pheno-
type in OXYS rats has much in common with the devel-
opment of AD [19]. Neurodegenerative changes
observed in the OXYS retina could be an ocular mani-
festation of systemic disease processes. The results of
the present study suggest that genes involved in ribonu-
cleoprotein complex biogenesis may also be relevant for
the accelerated-senescence brain phenotype in OXYS
rats. These data are in full compliance with the reports
that impairments in protein synthesis may be some of
the earliest neurochemical alterations in AD and that
the RNA splicing alterations associated with the ribonu-
cleoprotein complex are adversely affected early in the
development of AD [48, 49].
We found that the WAG/OXYS-1.2 congenic chromo-
somal segment delineated in our mapping experiment
contains the Fxn gene, which is a strong candidate for
an Arrd2 locus associated with age-related retinal degen-
eration in rats as reported in the Rat Genome Database
[50]. Nevertheless, Fxn does not seem to be a candidate
gene associated with retinopathy development in the
congenic rats and OXYS rats because we did not detect
either nonsynonymous SNPs in the coding sequence ordifferential expression of Fxn in the retina of the con-
genic rats [24].
Three genes—Asrgl1 (also known as Gliap, which
encodes atypical mammalian type I cytosolic L-
asparaginase), Dhdh (encoding dihydrodiol dehydrogen-
ase), and Gpha2 (encoding the α2 subunit of thyrostimu-
lin)—were found to be differentially expressed in the
retina of the congenic rats when compared to OXYS rats
and do not fall into the congenic segments. Thus, our data
point to a differential effect of the genetic background on
the regulation of these genes. We can hypothesize func-
tional mutations that take place in the corresponding
regulatory sequences, but further studies are needed. The
Asrgl1, Dhdh, and Gpha2 genes are located within at least
two QTLs that are reported in the Rat Genome Database
and are associated with behavioral abnormalities. This ob-
servation indicates that these genes may have an effect on
the behavioral phenotype of OXYS rats.
The level of Asrgl1 mRNA was significantly higher in
the retina of both congenic rats than in the retina of
OXYS rats (adjp-value 0.0342 and 0.0000013 for WAG/
OXYS-1.1 and WAG/OXYS-1.2 strains, respectively).
The corresponding L-asparaginase protein is particularly
abundant in the brain, where it was shown to be exclu-
sively expressed in astrocytes and to be present in struc-
tures reminiscent of glial endfeet. These data suggest the
involvement of ASRGL1 L-asparaginase in astroglial
production of the neuroactive amino acid L-aspartate
[51]. It was reported that a missense mutation in
ASRGL1 leads to photoreceptor degeneration resulting
in progressive vision loss [52]. The Dhdh gene is located
in a genomic region associated with tameness and ag-
gression, and the corresponding protein product is asso-
ciated with the metabolism of xenobiotics by
cytochrome P450 according to KEGG pathways [53].
The strongest expression differences between the brains
of tame and aggressive rats were shown for the Dhdh
gene. The Gpha2 gene is encoding a glycoprotein hor-
mone alpha 2 subunit of heterodimeric corticotroph-
derived glycoprotein hormone also referred to as thyros-
timulin. The results of immunohistochemical analysis
suggest that thyrostimulin is widely distributed in the rat
central nervous system [54] and likely performs a critical
function in the activation of thyroid-stimulating hor-
mone receptor [55].
Summarizing all the data, we believe in the exist-
ence of a complex genetic architecture underlying the
accelerated-senescence phenotype of OXYS rats, while
the genetic components driving neurodegenerative al-
terations in OXYS rats’ retina and brain can probably
be dissected. Nevertheless, further research is needed
to determine the actual role of the identified candi-
date genes in formation of the accelerated-senescence
phenotype in OXYS rats.
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It is useful to suppose that formation of an integrated
phenotype of aging can be achieved on the basis of mul-
tiple traits that may have weak correlations but share the
underlying genetic architecture. This notion is based on
the hypothesis that convergent results from multiple
aging-related traits will point up the pleiotropic signals
responsible for the overall rate of the aging process. In
the present study, we carried out comprehensive pheno-
typing of two original congenic strains that develop early
cataract and retinopathy. The results offer several puta-
tive correlations linking the candidate genes and path-
ways to the etiology of age-related neurodegenerative
changes in OXYS rats’ retina and brain. On the basis of
the above findings, the WAG/OXYS-1.1 and WAG/
OXYS-1.2 congenic rat strains can be considered a valu-
able tool for further research aimed at the genetic dis-
section of the accelerated-senescence phenotype in
OXYS rats and the relations among the candidate genes.
Methods
Animals
Male rats of the senescence-accelerated OXYS strain,
WAG/OXYS-1.1 and WAG/OXYS-1.2 congenic strains,
inbred Wistar Albino Glaxo (WAG) strain with a normal
phenotype, and outbred Wistar stock with a normal
phenotype were used in the study. All experimental ani-
mals were maintained by the Breeding Experimental
Animal Laboratory of the Institute of Cytology and Gen-
etics (SB RAS) as described previously [19]. The OXYS
rat strain was derived from Wistar stock as described
earlier [56]. The congenic rats show spontaneously de-
veloping cataract and retinopathy. The congenic rat
strains were originally created at the Institute of Cy-
tology and Genetics, (SB RAS), and the breeding scheme
used to generate these congenic rats was published earl-
ier [23]. Rats of the 9th generation of WAG/OXYS-1.1
and WAG/OXYS-1.2 strains were used for phenotypic
characterization in the study. Twenty-day-old congenic
rats of the 11th generation were previously used to ob-
tain RNA-Seq data that are further analyzed in the
study.
Ophthalmoscopic examination
This examination was performed on 2-, 3-, and 12-
month-aged rats of the parental (OXYS and WAG), and
congenic (WAG/OXYS-1.1 and WAG/OXYS-1.2)
strains after dilatation with 1% tropicamide using Beta
Direct Ophthalmoscope (Germany) with a slit lamp. As-
sessment of the stages of cataract and retinopathy was
carried out according to the Age-Related Eye Disease
Study (AREDS) grade protocol [25] through the use of
evaluation rating scales from 0 to 3 as described previ-
ously [23].Morphological and morphometric analyses of rat retinas
For the histological analysis, an AxioScop 2 Plus light
microscope (Zeiss, Germany) was used. The study was
carried out on OXYS, WAG, WAG/OXYS-1.1, and
WAG/OXYS-1.2 rats aged 3 months (n = 5 per group),
10 months (n = 5 per group), and 16 months (n = 3 per
group). These rats were ophthalmologically examined
immediately before the tissue sampling and preparation.
The eyeballs were immediately excised on ice, fixed in
Carnoy’s fluid (alcohol: chloroform: glacial acetic acid at
6:3:1) during 2.5 h, and then washed thoroughly with
96% alcohol. Then the posterior wall of the eye was col-
lected, fixed in 12% neutral formalin, carefully washed in
water, dehydrated in ascending alcohol concentrations,
and embedded in paraffin according to the standard
technique. Serial semithin (4 to 5 μm thick) frontal sec-
tions were prepared on an LKB-4 ultratome (Sweden).
After staining with hematoxylin and eosin (H&E) 5 ran-
dom visual fields for each retina were examined using a
Carl Zeiss Axiostar plus microscope (Germany). The
frame area of 900 μm2 for the magnification of 10 × 100
was selected. The specific morphological parametres in-
cluding areas of choroid vessels and the numbers of gan-
glion neurons were calculated separately using the
Axiovision 4.8 software (Carl Zeiss Vision, Hallberg-
moos, Germany).
Behavioral testing
Behavioral testing started when the rats of OXYS, WAG,
WAG/OXYS-1.1 and WAG/OXYS-1.2 experimental
groups (n = 12 to 15 per group) reached the age of
3 months. Standard tests were conducted in the following
order: the first one comprised observation of locomotor
exploratory activity in an OF test at the age of 3 months
[57]; the assessment of the degree of anxiety was con-
ducted in the EPM test 1 week apart [58]; and then the
same experimental animals underwent memory tests in
the 8-arm radial maze at the age of 5 months [59]. The be-
havioral testing sessions were conducted between
8:00 a.m. and 12:00 p.m. because of a major circadian in-
fluence at least on the OF and EPM performance [60],
and the testing order of the groups was counterbalanced.
OF test
The apparatus consisted of an opaque plastic square
(100 × 100 cm) surrounded by walls of 40 cm in height.
A central area was arbitrarily defined as a square of 30 ×
30 cm. A rat was assumed to be in the central area when
its four paws were touching it. A central light source
(100 W) on the ceiling provided invariant illumination
in an otherwise dark room. Each rat was placed in the
same corner of the maze facing the same direction, and
its behavior was analyzed for 5 min. The following
dependent variables were recorded: total distance
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central area, time spent in the central area, number of
grooming episodes, and the number of boluses.
EPM test
The apparatus consisted of an opaque plastic central
square platform (11 × 11 cm) with four arms (50 × 10 cm)
forming a “plus” sign: two opposite arms without walls
(open arms) and two opposite arms with 40-cm-high walls
(closed arms). Each rat was facing an open arm and
allowed to freely explore the maze for 5 min. The following
dependent variables were recorded: total distance moved,
the number of closed-arm entries, number and percentage
of open-arm entries ([number of open arm entries × 100]/
Total entries) and percentage of time spent in open arms
([time spent in open arms × 100]/300 s).
Radial 8-Arm maze test
The apparatus consists of eight equally spaced arms
(67 × 10 × 20 cm), made of grey Plexiglas and radiating
from a circular central platform 26 cm across (Open
Science, Russia). Each arm was equipped with a fully
retractable guillotine door at its entrance and a magnetic
food pellet tray at its end. Memory testing per se started
after 2 days of habituation to the maze. According to the
standard test variation, 2 trials per day with a 2-h inter-
val between the trials were administered to each rat dur-
ing 10 subsequent training days. An animal was placed
on the central platform facing the same starting arm.
After 20 s, all the doors were opened simultaneously,
and rat’s behavior was analyzed for 15 min or until all
four food-associated arms were visited. The food reward
(dry cereal pellets, Lyubyatovo, Russia) was always placed
in the same four arms of the maze. The following
dependent variables were recorded: the total number of
visited arms, the number of entries and time spent in arms
with/without food reward, number of rearings. Memory
errors were subdivided into reference memory (i.e., enter-
ing an arm that was never baited) and working memory
errors (re-entering a previously baited arm during a trial).
Working and reference memory performance was com-
bined for four sessions for each animal: day 1 (a rat still
getting acquainted with the maze), days 2–4, days 5–7,
and days 8–10 of training, in order to control errors.
MRI
These experiments on the brains of 12-month-old rats of
parental (OXYS, WAG) and congenic (WAG/OXYS-1.1,
WAG/OXYS-1.2) strains were performed on a horizontal
11.7 T magnet (Bruker, BioSpec 117/16 USR, Germany)
operating at the 1H resonance frequency of 500 MHz.
Eight rats per group were analyzed. Rats were anesthetized
by injection of thiopental sodium (60 mg/kg intraperitone-
ally), during the procedures. The animal was placed in theprone position on an animal bed which was then slid into
the magnet bore. A respiratory pillow placed underneath
the lower torso was used to monitor respiration (SA
Instruments, Stony Brook, NY, USA). The Multi Slice,
Multispin Echo (MSME) technique was used. T2-
weighted images (T2 WI) were obtained with the follow-
ing scanning parameters: the repetition time (TR),
4200 ms; echo time (TE), 55 ms; matrix (MTX), 256 ×
256; slice thickness, 1 mm; distance between consecutive
slices, 1.2 mm; number of slices, 9; field of view (FOV),
4.0 × 4.0 cm. The brain structures were identified using
the Rat Brain Atlas of Paxinos & Watson [61]. The foci of
demyelination were visualized as hyperintense areas on
the T2-weighed images, the number of which was counted
in all axial sections of the brain.
Gene expression analysis
The sets of DE genes in the retina of 20-day-old OXYS,
WAG/OXYS-1.1, and WAG/OXYS-1.2 rats were ana-
lyzed previously as described by Korbolina et al. [24].
Briefly, the RNA-seq data were obtained in the amount
of 40 million raw short reads per sample (in triplicate
for OXYS and WAG/OXYS-1.2 strains, one pooled sam-
ple from the WAG strain and one pooled sample from
the WAG/OXYS-1.1 strain). The analysis pipeline started
with raw data. The Cutadapt tool have been embedded to
remove adapters [62]. The pre-processed high quality
reads were mapped onto the Rnor_5.0 reference genome
assembly with TopHat2 [63]. ENSEMBL gene annotation
data were used for the data conversion. The resulting gene
count tables were utilized by DESeq package [64]. In all
cases, P-values were corrected to q-values using the
Benjamini-Hochberg method. The genes surviving at
q <0.01 were determined as differentially expressed.
QTL tracking on rat chromosome 1
Here, we compared the lists of genes of two QTL locations
on chromosome 1 of OXYS rats with the RGD data for the
rat QTLs. Two putative QTLs affecting the accelerated-
senescence phenotype of OXYS rats were determined using
F2 hybrids bred by a reciprocal cross with the WAG strain
in the regions of microsatellite markers D1Rat30 and
D1Rat219 (QTL1) and D1Rat219 and D1Rat81 (QTL2).
The significant logarithm (base 10) of odds (LOD scores >
3) were obtained for early cataract (QTL2), and retinopathy
(QTL1 and QTL2). In addition, the LOD scores ranging
from 2.5 to 3 were obtained for some behavioral parameters
recorded in the OF and EPM tests, including the time spent
in the central area in both tests, the number of rearings in
the OF test, and the number of grooming acts in the EPM
test. These data led to the assumption that QTL1 and
QTL2 might affect anxiety and the exploratory activity
rate—and therefore certain behavioral signs of brain
neurodegeneration—in OXYS rats [23].
Table 2 The Rat Genome Database report for the analyzed quantitative trait loci on RNO1
RGD ID Locus Name Start End LOD Trait
1354647 Despr8 Despair related QTL 8 1 24368159 – locomotor activity trait (VT:0001392)
1354653 Despr9 Despair related QTL 8 185390068 230390068 – locomotor activity trait (VT:0001392)
738028 Anxrr12 Anxiety related response QTL 12 141296374 186296374 4.90 locomotor activity trait (VT:0001392)
738022 Anxrr13 Anxiety related response QTL 13 91093646 136093646 4.60 locomotor activity trait (VT:0001392)
738006 Anxrr14 Anxiety related response QTL 14 141296374 186296374 4.00 locomotor activity trait (VT:0001392)
2313402 Anxrr24 Anxiety related response QTL 24 49147799 156446783 – aggression-related behavior trait (VT:0015014)
Start/End: start and end positions of QTL on RNO1, respectively, bp; LOD: the corresponding logarithm of the odds ratio, if reported
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according to the data present in the Rat Genome Data-
base: “anxiety,” “anxiety response,” “locomotor activity,”
and “behaviour.” These QTL reports (Table 2) provide a
phenotype description, mapping, strain information, and
links to candidate genes, if determined.Functional enrichment analysis
The enrichment analysis was used to characterize the
genes localized within a certain RNO1 chromosome seg-
ment and to extract candidate gene clusters and/or path-
ways that may be clinically meaningful against the
criterion of GO annotation. We also looked for individ-
ual candidate genes with functions that could correlate
with the phenotypic outcome.
We used the functional annotation tool available in
the Database for Annotation, Visualization and Inte-
grated Discovery (DAVID) [65]. Clustering and grouping
of the colocalized genes into functionally related gene
groups (or classes) were performed using the DAVID
gene functional classification tool based on shared func-
tional annotation. This approach switches the functional
annotation analysis from a gene-centric analysis to a
biological-module-centric analysis. The minimum gene
number in a seeding group was set to 2, and the similar-
ity threshold was set to the minimum similarity thresh-
old of 0.3, as suggested by the DAVID consortium. All
remaining parameters were kept at their default values.Statistical analysis
The data were subjected to 2-way ANOVA or repeated
measures ANOVA in the statistical package Statistica 6.0
(StatSoft, Tulsa, USA). A Newman-Keuls post hoc test
was applied to significant main effects and interactions
in order to estimate the differences between particular
sets of means, unless noted otherwise. One-way ANOVA
was used for individual group comparisons. The signifi-
cance level was set to 5%. All data are shown as the
mean ± SEM.Additional files
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